H. Lundbeck A/S (HLBBF)

OTCMKTS · Delayed Price · Currency is USD

6.07

0.00 (0.00%)

At close: Mar 13, 2026

Revenue by Segment

Financials in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research, Development, Production and Sale of Pharmaceuticals	24.63B	22.00B	19.91B	18.25B	16.30B
Research, Development, Production and Sale of Pharmaceuticals Growth	11.93%	10.51%	9.13%	11.95%	-7.77%
Total	24.63B	22.00B	19.91B	18.25B	16.30B
Total Growth	11.93%	10.51%	9.13%	11.95%	-7.77%

Revenue by Geography

Financials in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Europe	5.82B	5.15B	4.63B	4.25B	3.82B
Europe Growth	13.08%	11.19%	8.84%	11.28%	-
International Operations	4.86B	5.22B	4.99B	5.20B	4.60B
International Operations Growth	-6.92%	4.57%	-4.07%	13.18%	13.31%
United States	13.29B	11.33B	9.83B	9.10B	7.48B
United States Growth	17.32%	15.22%	7.99%	21.67%	-15.03%
Unallocated	666.00M	314.00M	464.00M	-311.00M	400.00M
Unallocated Growth	112.10%	-32.33%	-	-	-19.35%
Total	24.63B	22.00B	19.91B	18.25B	16.30B
Total Growth	11.93%	10.51%	9.13%	11.95%	-7.77%

Source: S&P Global Market Intelligence.